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Emerging targets: Molecular mechanisms of cell contact-medi- at contact inhibition (summarized in Table 1) suggest
ated growth control. Contact inhibition of cell proliferation that the cellular program of growth arrest controlled by
evokes a unique cellular program of growth arrest compared with cell-cell contact is unique compared with the growthstress, age, or other physical constraints. The last decade of
arrest induced by stress or age. Expression of growthresearch on genes activated by cell-cell contact has uncovered
arrest-specific (GAS) or growth arrest- and DNA dam-features of transmembrane signaling, cytoskeletal reorganiza-
tion, and transcriptional control that initiate and maintain a age-inducible (GADD) genes is induced by both serum
quiescent phenotype. This review will focus on mechanisms starvation and contact inhibition [3], or by both serum
controlling contact inhibition of cell proliferation, highlighting starvation and DNA-damaging agents, respectively [4].specific gene expression responses that are activated by cell-cell
Although the growing list of genes activated by contactcontact. Although a temporal framework for imposition of
inhibition include the GAS family by definition, a num-these mechanisms has not yet been well described, contact
inhibition of cell proliferation clearly requires their coordinated ber of important discoveries include genes that are not
function. Novel targets for intervention in proliferative disor- activated by stress. The degree to which the cellular
ders are emerging from these studies. program of contact inhibition will diverge from GAS
genes, GADD genes, growth arrest imposed by limiting
cell-extracellular matrix surface area contact [5] or cell
senescence [6] remains to be determined. This reviewThe capacity for cells to judiciously regulate prolifera-
will discuss the molecular mechanisms controlling thetive responses in the context of cell-cell contact is a
initiation and maintenance of contact inhibition (Fig. 1).fundamental requirement for the organization and main-
tenance of specialized tissues in multicellular organisms.
Indeed, contact-mediated inhibition of growth is not re- WHICH CELL-CELL CONTACT IS
stricted to cells in tissues but is a general property dis- MOST IMPORTANT?
played by cultured primary cells of many types, including
Theoretically, contact inhibition could be controlledfibroblasts, smooth muscle, endothelial, epithelial, and
by a limited number of, or possibly one, cell surface mol-other lineages. Increasing cell-cell contact in adherent
ecule(s). However, recent reports reveal that loss ofcells eventually blocks the growth factor and integrin-
specific cell surface moieties or disruption of any onemediated stimuli to proliferate in vitro. This contact or
cell-cell contact structure may be singularly capable ofdensity-dependent inhibition of cell proliferation (herein
releasing cells from contact inhibition. For some time,referred to as contact inhibition) is achieved at a cell-
it has been known that contact inhibition-induced geneculture specific saturation density.
expression and synthesis of plasma membrane ganglio-One parameter that distinguishes cancer-derived trans-
sides is lost in transformed cells [7]. Exogenous additionformed cells from primary cells cultured from normal
of soluble gangliosides suppress proliferation by inhib-tissue is the loss of contact inhibition [1, 2]. In fact, an
iting RPTK (receptor protein tyrosine kinase) activationimportant window into understanding contact inhibition
[8–11]. A possible mechanism for this RPTK inhibitionhas been the identification of specific mRNA transcripts
was lacking until it was shown that return of contact inhi-that are induced by cell-cell contact in normal, but not
bition in A431 cells by ganglioside GM3 is mediated throughtransformed, cells. Reports on genes that are activated
RPTP- (receptor protein tyrosine phosphatase) [12].
Thus, heterotopic interaction between upregulated gan-
Key words: contact inhibition, growth arrest, quiescence, review. gliosides and upregulated RPTPs (see Table 1) on adja-
cent cells may be a key mechanism of growth arrest. 2002 by the International Society of Nephrology
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Fig. 1. A proposed model integrating specific molecular mechanisms that initiate and maintain contact inhibition. INITIATION: Activation of
receptor protein tyrosine phosphatases (RPTP) and contactinhibin by cell surface molecules on adjacent cells inhibits mitogenic pathways downstream
of receptor protein tyrosine kinase- (RPTK) and integrin-activated kinases such as ras and src. This leads to the suppression of cyclin D expression
and transcriptional activation of ras- and src-suppressed genes encoding cell-cell contact proteins, including occludin-1 (ocl-1) in tight-junctions
(T-J), -actinin (-act) in adherens-junctions (A-J), and connexin43 (Cx43) in gap-junctions (G-J), favoring cytoskeletal polymerization between
affinity partners. G1-phase inhibitors are also up-regulated and may additionally be transactivated by phosphorylated (P) S100C. MAINTENANCE:
C/EBP transcription factors contribute to ongoing mechanisms from the initiation phase by activating genes that lead to a fully differentiated and
quiescent phenotype.
Contactinhibin was similarly discovered to control suppressed gap-junction protein [18], resulted in signifi-
contact inhibition through assays that challenge prolifer- cantly higher saturation densities in BALB/c 3T3 cells
ating fibroblasts with cell membrane fractions [13]. Un- [19]. Re-expression of connexin43 reverted transformed
like membrane gangliosides, however, the soluble form cells to contact inhibited growth marked by dye coupling
of contactinhibin, a 60–70 kD membrane glycoprotein, between cells [20]. Using similar methodology, a recent
does not inhibit growth, nor is its cell surface expression study showed that the re-expression of occludin-1, a raf-
lost with transformation. The inhibitory activity of con- suppressed tight-junction protein, resulted in return of
tactinhibin is delegated to its “downstream” membrane contact inhibition in transformed salivary epithelial cells
receptor, CiR, which is downregulated and hyperphos- [21]. This coincided with recovery of claudin-1 protein
phorylated in transformed cells [14]. levels, relocation of ZO-1 to tight-junctions, and redistri-
In fact, aberrant expression or function of a number of bution of E-cadherin to lateral membranes. Moreover,
“downstream” cell-cell structural proteins can singularly
the expression and assembly of tight-junction proteinsrelease cells from contact inhibition. Reviewed else-
following disruption of raf pathways using MEK1 inhibi-where [15, 16], the importance of adherens-junctions in
tors in ras-transformed epithelial cells was found to pre-growth control is well-described. The function of ad-
cede the appearance of E-cadherin-based junctions [22].herens-junctions in contact inhibition is to regulate the ac-
This challenges the belief that adherens-junction is thetivity of -catenin, as modest overexpression of -catenin
primary cell-cell contact structure mediating contact in-is sufficient to maintain proliferation at high cell density
hibition. In total, these observations strengthen the no-[17]. However, less attention has been focused on the
tion that contact inhibition requires the coordinated func-role of gap-junctions and tight-junctions. Oligonucleo-
tide antisense-inhibited expression of connexin43, a ras- tion of a number of cell-cell contact proteins.
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Table 1. Genes up-regulated at contact inhibition
Gene Proposed mechanism of action Reference
Secreted factors
Acidic-FGF Survival/anti-apoptotic factor [62]
Clusterin Heterodimeric glycoprotein promoting anti-apoptosis [63]
Decorin Binds TGF- and thrombospondin, and is a novel ligand for EGF receptor, [64, 65]
leading to p21Waf1 upregulation
GAS6 Vitamin K-dependent ligand (related to protein S) of Axl family of receptor [66–68]
protein tyrosine kinases, inhibiting apoptosis
p20K Member of the lipocalin family of lipid-binding proteins, resulting in [56]
enhanced transport of polyunsaturated fatty acids
Non-secreted factors
Cell cycle components
Cyclin D2 Sequestration of the CDK2 catalytic subunit [69]
p16Ink4a Inhibition of CDK4 and 6, with p16Ink4a / cells exhibiting higher saturation
density but no foci formation compared with p16Ink4a / cells [40, 41]
p27Kip1 Inhibition of CDK2, 4, and 6, however p27Kip1 / cells exhibit no higher
saturation density or foci formation compared with p27Kip1 / cells [39, 42]
Transcription or translation factors
C/EBP- Leucine-zipper type transcription factor that activates a “quiescence-
responsive unit” [56]
C/EBP- Leucine-zipper type transcription factor that activates genes associated with
growth arrest and differentiation [55]
C/EBP- Leucine-zipper type transcription factor that activates genes associated with
growth arrest and differentiation [55]
GAS5 Non-protein-coding multiple small nucleolar RNA (snoRNA) involved in
growth-dependent regulation of protein synthesis [70]
Transmembrane phosphatases or kinases
GAS9 PDGF-receptor that promotes cell “competence” for cell cycle progression [71]
HPTP- Enhanced PTPase activity [72]
PTPRJ Enhanced PTPase activity [51, 52]
RPTP- Enhanced PTPase activity [73]
RPTP- Enhanced PTPase activity [74]
Cytoskeletal proteins
Caveolin Signal molecule scaffolding protein in caveolae that negatively regulates the
ERK1/ERK2 MAP kinase cascade [30, 31]
GAS1 Novel integral membrane protein of unknown function; however, antisense
RNA-inhibited expression induces high saturation density [75]
GAS2 Actin-associated protein involved in microfilament reorganization [76]
GAS3 Transmembrane glycoprotein of unknown function associated with heredi-
tary proliferative neuropathies [77]
MARCKS F-actin cross-linking in cytoskeletal reorganization [78, 79]
p18H-rev107 ras-suppressed gene of unclear function [80]
SSeCKS Cytoplasmic sequestration of G1 phase cyclins and scaffolding of signaling
molecules [32, 36]
Other signaling proteins
Neurofibromin Increased GTPase activating protein activity, maintaining differentiation [81]
PC5 Subtilisin/kinin-like endoprotease that cleaves trans-membrane
phosphatases [82]
PI 3-kinase Role unclear [83]
PKC- Role unclear [78]
PKC- Role unclear [78]
S100B EF-hand Ca2-binding protein that facilitates nuclear accumulation of p53 [59]
S100C EF-hand Ca2-binding protein with phosphorylation dependent cytoplasmic-
to-nuclear translocation, leading to p16Ink4a and p21Waf1 up regulation [57]
“CLASS II” TUMOR SUPPRESSORS: reexpressed. The paradoxical dominance of one reex-
CYTOSKELETAL CONTROL OF pressed cytoskeletal protein over signaling pathways may
CONTACT INHIBITION be by favoring cytoskeletal polymerization between af-
finity partners, as has been modeled for focal adhesionStudies on “class II” tumor suppressors, genes that
assembly [27]. This new cytoskeletal network likely im-are not altered at the DNA level (“class I”) [23], have
pacts aberrant signaling by normalizing spatial-temporalfurther highlighted the importance of the cytoskeleton
constraints on signaling proteins that are organized byin contact inhibition. Similar to occludin-1, a number of
the cytoskeleton [28]. Direct evidence for a similar mech-cytoskeletal proteins (examples: -actinin, tropomysin,
anism in contact inhibition has come with recent reportsgelsolin [24–26]) are transcriptionally downregulated in
transformed cells and establish contact inhibition when on two cytoskeletal scaffolding proteins.
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Caveolin, the principal membrane protein component STUDIES IN ENDOTHELIUM: CELL SURFACE
SIGNALING IN CONTACT INHIBITIONof caveolae, has been characterized as a “general kinase
inhibitor” based on the observation that its signal mole- During angiogenesis, inhibitory signals that maintain
cule scaffolding domain inhibits a number of signal trans- the contact inhibited network of endothelium in a parent
duction pathways [29]. Interaction between the caveolin vessel must be overcome to contribute cells to new out-
cytosolic membrane-proximal scaffolding domain and growth. This model is supported by observations that both
the caveolin-binding motif in a number of signaling mole- tyrosine phosphatase activity and RPTPs are up-regu-
cules, including G-protein  subunits, H-Ras, Src family lated, and intracellular mitogenic pathways inhibited, in
tyrosine kinases, PKC isoforms, EGF-R, Neu, and eNOS, confluent endothelial cells. Endothelial cells, along with
inhibits their activity. Similar to other “class II” tumor- other cell types, exhibit higher membrane phosphatase
suppressing cytoskeletal proteins, caveolin-1 mRNA and activity at confluence than during subconfluent growth
protein are downregulated in transformed cells, and re- or growth arrest by serum starvation [46–49]. Mitogenic
expression establishes contact-inhibited growth. Recently, pathways are inhibited downstream of Ras-MEK1 in con-
it was discovered that caveolin-1 expression is upregu- fluent endothelial cells [50]. Moreover, addition of the
lated by cell-cell contact, whereas antisense RNA-inhib- phosphatase inhibitor, sodium orthovanadate, to conflu-
ited expression in NIH3T3 cells was sufficient to constitu- ent endothelial cells activates the ERK1/ERK2 MAP ki-
itively activate the ERK1/ERK2 MAP kinase cascade nase and PI 3-kinase/Akt pathways, followed by cyclin D
with loss of contact inhibition [30]. This upregulated expression and p27Kip1 downregulation [49]. Therefore,
expression was marked by subcellular redistribution of upregulated RPTPs likely attenuate key mitogenic path-
caveolin-1 to sites of cell-cell contact [31]. ways at contact inhibition. However, little is known
SSeCKS similarly controls mitogenic pathways by scaf- about how these RPTPs are activated by cell-cell contact.
folding signaling molecules in the cytoplasm. However, Studies on PTPRJ (originally called density enhanced
unlike caveolin-1, the upregulated expression of SSeCKS phosphatase-1 [51]), a 220 kD RPTP abundantly ex-
at contact inhibition leads to its direct interaction with pressed in the endothelium of the kidney, provide evidence
cell cycle components [32]. Detected in screens for src- for how RPTPs may be activated at contact inhibition
and ras-suppressed “type II” tumor suppressors [18, 33], [52]. In primary human renal microvascular endothelial
SSeCKS is a major PKC substrate with multivalent scaf- cells, PTPRJ clusters at sites of cell-cell contact, suggesting
folding activity for PKC, PKA, and Ca2-calmodulin that cell-contact-induced oligomerization may be impor-
[34, 35]. Inducible ectopic expression in subconfluent tant for activity. This notion was supported by observa-
cells disengaged SSeCKS from its cell-cycle-regulated tions that oligomerizing bivalent antibody directed against
expression [36] resulting in growth arrest in G1 [32]. This PTPRJ ectodomains arrested subconfluent endothelial
was accompanied by elaboration of SSeCKS-staining cell cell proliferation in the presence of growth factors, whereas
processes [37], mimicking the expression of SSeCKS in monovalent antibody had no effect. Cells were blocked
morphologically differentiating cells during embryogen- from entering the G1/S transition without increased apo-
esis [38]. Importantly, the G1 arrest in subconfluent ptosis. Importantly, FGF-induced angiogenesis, in an in
SSeCKS overexpressors recapitulated the cell cycle con- vivo mouse corneal pocket assay, was blocked by biva-
trol by SSeCKS at contact inhibition by at least two lent antibody, but not by monovalent antibody. Thus,
mechanisms: ERK2-dependent decreases in cyclin D, and loss of contact inhibition in the parent vessel likely re-
cytoplasmic sequestration of G1-phase cyclins by interac- quired disruption of oligomerized PTPRJ. Interestingly,
tion with SSeCKS’ cyclin binding motifs [32]. SSeCKS’ challenging proliferating endothelial cells with endothe-
up-regulation at contact inhibition is similar to two other lial membrane fractions arrest growth [53]. A key study
G1-phase inhibitors, p27Kip1 and p16Ink4a [39, 40]. However, will be to discover the factor on adjacent endothelial cell
only loss of p16Ink4a or SSeCKS function [32, 41], not p27Kip1 membranes that causes PTPRJ oligomerization.
[42], results in higher saturation densities, suggesting that
some G1-phase inhibitors are more critical for contact
WHAT INITIATES GENE EXPRESSION ATinhibition. Accumulation of hypophosphorylated Rb in
CONTACT INHIBITION?growth-arrested subconfluent SSeCKS overexpressors
[32] or confluent fibroblasts [43] is consistent with the Immediate phosphatase inactivation of mitogenic sig-
naling at contact inhibition likely leads to expression ofneed for active transcriptional repression by complexed
Rb-E2F to initiate contact inhibition [44]. This suggests some genes. However, additional transcriptional mecha-
nisms are emerging. C/EBP (CCAAT/enhancer-bindingthat the contact inhibition observed in cells deleted for
specific Rb isoforms is through compensation from other protein) transcription factors are important in the differ-
entiation and function of many tissues [54]. Two reportsRb family members [45]. Thus, caveolin and SSeCKS
act at the intersection of cytoskeletal reorganization and have shown that certain C/EBP isoforms are upregulated
at contact inhibition in specific cells: C/EBP- and C/EBP-mitogenic control in contact inhibition.
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